Evidence map›Paper›PMID 17482889›Full record

ReviewDNA repair2007

MGMT: a personal perspective.

Sankar Mitra

Abstract readHistorical ArticleReview
In one paragraph

Review in DNA repair, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Targeting the DNA damage response for cancer therapy.Biochemical Society transactions · 2023
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Cytotoxic and mutagenic properties ofThe Journal of biological chemistry · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sankar MitraDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. samitra@utmb.edu

Funding

STRUCTURE AND REGULATION OF DNA REPAIR GENES OF MAMMALSR01CA053791 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI MITRA, SANKAR · 1991 to 2011
$4.0M
DNA REPAIR AND NITROSAMINE-INDUCED CARCINOGENESISR01CA031721 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI MITRA, SANKAR · 1985 to 1995
–
REGULATION OF ALKYLATION DAMAGE REPAIR GENES OF MAMMALSR01ES007572 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI MITRA, SANKAR · 1995 to 1998
–
NCI NIH HHS R01 CA053791NCI NIH HHS R01 CA31721NCI NIH HHS R01 CA53791NIEHS NIH HHS R01 ES07572
6 · The paper itself

Abstract

This review describes the history of studies on alkylation damage of mammalian genomes and its carcinogenic consequences that led to the discovery of a unique DNA repair protein, named MGMT. MGMT repairs O(6)-alkylguanine, a critical mutagenic lesion induced by alkylating agents. The follow-up studies in mammalian cells following the discovery of the ubiquitous repair protein in E. coli are summarized.

Indexed as

O(6)-Methylguanine-DNA MethyltransferaseAlkylating AgentsAnimalsCloning, MolecularDNA Modification MethylasesDNA RepairDNA Repair EnzymesEscherichia coliGuanineHistory, 20th CenturyHistory, 21st CenturyHumansMethylnitronitrosoguanidineMutationTumor Suppressor ProteinsAlkylating AgentsDNA Modification MethylasesDNA Repair EnzymesGuanineMethylnitronitrosoguanidineMGMT protein, humanO-(6)-methylguanineO(6)-Methylguanine-DNA MethyltransferaseTumor Suppressor Proteins

Identifiers

PMID17482889
PMCPMC2692271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.